⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KAPA News
Kairos Pharma, Ltd.
KAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm
globenewswire.com
KAPA
Kairos Pharma Investor News: Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation – KAPA
businesswire.com
KAPA
Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation – KAPA
businesswire.com
KAPA
Form 8-K
sec.gov
KAPA
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
businesswire.com
KAPA
カイロス・ファーマ（Kairos Pharma, Ltd.）、Celyn Therapeuticsから臨床段階の腫瘍領域資産2件を戦略的に取得するタームシート締結を発表
businesswire.com
KAPA
Kairos Pharma, Ltd.宣布簽署投資條件書，戰略性收購Celyn Therapeutics旗下兩份臨床腫瘤資產
businesswire.com
KAPA
Kairos Pharma, Ltd.宣布簽署投資條件書，戰略性收購Celyn Therapeutics旗下兩份臨床腫瘤資產
businesswire.com
KAPA
Kairos Pharma, Ltd.宣布签署战略资产收购条款清单 拟收购Celyn Therapeutics两项临床阶段肿瘤资产
businesswire.com
KAPA
Kairos Pharma, Ltd. kondigt ondertekening aan van term sheet voor strategische overname van twee klinische oncologie-activa van Celyn Therapeutics
businesswire.com
KAPA